Company: MYSEW
Filing Date: 2025-02-10
Form Type: 424B5
Source: 0001213900-25-011767
Chunk: 18

Company: Myseum, Inc.
Filing Date: 2025-02-10
Form: 424B5
Chunk 18
---
sell substantial amounts of common stock or securities exercisable or convertible into or exchangeable for common stock.

<div align='center'>S-9</div>

The actual number of shares we will
issue under the Sales Agreement, at any one time or in total, is uncertain.

Subject to certain limitations
in the Sales Agreement and compliance with applicable law, we have the discretion to deliver instruction to the Sales Agent to sell shares
of our common stock at any time throughout the term of the Sales Agreement. The number of shares that are sold through the Sales Agent
after our instruction will fluctuate based on a number of factors, including the market price of our common stock during the sales period,
the limits we set with the Sales Agent in any instruction to sell shares, and the demand for our common stock during the sales period.
Because the price per share of each share sold will fluctuate during this offering, it is not currently possible to predict the number
of shares that will be sold or the gross proceeds to be raised in connection with those sales.

The common stock offered hereby will
be sold in “at the market offerings,” and investors who buy shares at different times will likely pay different prices.

Investors who purchase shares
in this offering at different times will likely pay different prices, and so may experience different levels of dilution, and different
outcomes in their investment results. We will have discretion, subject to market demand, to vary the timing, prices, and numbers of shares
sold in this offering. Investors may experience a decline in the value of the shares they purchase in this offering as a result of sales
made at prices lower than the prices they paid.

Our management will have broad discretion
over the use of the net proceeds from this offering, you may not agree with how we use the proceeds, and the proceeds may not be invested
successfully.

Our management will have broad
discretion in the application of the net proceeds from this offering, and our stockholders will not have the opportunity as part of their
investment decision to assess whether the net proceeds are being used appropriately. Because of the number and variability of factors
that will determine our use of the net proceeds from this offering, their ultimate use may vary substantially from their currently intended
use. The failure by our management to apply these funds effectively could harm our business. See “Use of Proceeds” on page
S-12 of this prospectus supplement for a description of our proposed use of proceeds from this offering.

Our common stock price may be volatile and